Cargando…
Allogeneic Stem Cell Transplantation with a Novel Reduced Intensity Conditioning Regimen for the Treatment of Patients with Primary Cutaneous T-cell Lymphomas
The prognosis of patients with mycosis fungoides (MF) and Sezary Syndrome (SS) varies greatly, from near normal life expectancy in patients with early stage, to a median survival of less than 2 years for those diagnosed with advanced stage disease. Initial response to treatment is almost always foll...
Autores principales: | Stamouli, Maria, Gkirkas, Konstantinos, Karagiannidi, Aggeliki, Iliakis, Theodoros, Chondropoulos, Spiros, Thomopoulos, Thomas, Nikolaou, Vassiliki, Pappa, Vassiliki, Papadavid, Evangelia, Tsirigotis, Panagiotis |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Atlantis Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8432398/ https://www.ncbi.nlm.nih.gov/pubmed/34595469 http://dx.doi.org/10.2991/chi.k.210529.001 |
Ejemplares similares
-
Repetitively Administered Low-Dose Donor Lymphocyte Infusion for Prevention of Relapse after Allogeneic Stem Cell Transplantation in Patients with High-Risk Acute Leukemia
por: Tsirigotis, Panagiotis, et al.
Publicado: (2021) -
Endothelial Injury Syndromes after Allogeneic Hematopoietic Stem Cell Transplantation: Angiopetin-2 as a Novel Predictor of the Outcome and the Role of Functional Autoantibodies against Angiotensin II Type 1 and Endothelin A Receptor
por: Vythoulkas, Dionysios, et al.
Publicado: (2023) -
Allogeneic Hematopoietic Stem Cell Transplantation for Mixed or Overlap Myelodysplastic/Myeloproliferative Disorders
por: Symeonidis, Argiris, et al.
Publicado: (2022) -
Ruxolitinib with resminostat exert synergistic antitumor effects in Cutaneous T-cell Lymphoma
por: Karagianni, Fani, et al.
Publicado: (2021) -
Apoptosis Induction and Gene Expression Profile Alterations of Cutaneous T-Cell Lymphoma Cells following Their Exposure to Bortezomib and Methotrexate
por: Mpakou, Vassiliki, et al.
Publicado: (2017)